Lupin to focus on the development of inhalers with near-zero global warming potential propellants

Lupin's R&D teams are working on products with a near-zero global warming potential propellant FRANKFURT, Germany, Oct. 28, 2024 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) today announced its focus on formulating respiratory inhalers by incorporating a propellant with...